Closing the mycetoma knowledge gap

被引:56
|
作者
van de Sande, Wendy [1 ]
Fahal, Ahmed [2 ]
Ahmed, Sarah Abdalla [3 ]
Alberto Serrano, Julian [4 ]
Bonifaz, Alexandro [5 ]
Zijlstra, Ed [6 ]
机构
[1] ErasmusMC, Dept Med Microbiol & Infect Dis, Wytemaweg 80, NL-3015 CE Rotterdam, Netherlands
[2] Univ Khartoum, Mycetoma Res Ctr, Khartoum, Sudan
[3] Westerdijk Fungal Biodivers Inst, Utrecht, Netherlands
[4] Hosp Independencia, Lab Micol, Santiago Del Estero, Argentina
[5] Gen Hosp Mexico, Dept Mycol, Dermatol Serv, Mexico City, DF, Mexico
[6] Rotterdam Ctr Trop Med, Rotterdam, Netherlands
关键词
Mycetoma; Madura foot; Host factors; Epidemiology; Diagnosis; Therapy; IN-VITRO SUSCEPTIBILITIES; BLACK-GRAIN EUMYCETOMA; MADURELLA-MYCETOMATIS; EXOPHIALA-JEANSELMEI; CAUSATIVE AGENTS; GENOME SEQUENCE; IDENTIFICATION; POLYMORPHISMS; FOOT; ACTINOMYCETOMA;
D O I
10.1093/mmy/myx061
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
On 28th May 2016, mycetomawas recognized as a neglected tropical disease by the World Health Organization. This was the result of a 4-year journey starting in February 2013 with a meeting of global mycetoma experts. Knowledge gaps were identified and included the incidence, prevalence, and mapping of mycetoma; the mode of transmission; the development of methods for early diagnosis; and better treatment. In this review, we review the road to recognition, the ISHAM working group meeting in Argentina, and we address the progress made in closing the knowledge gaps since 2013. Progress included adding another 9000 patients to the literature, which allowed us to update the prevalence map on mycetoma. Furthermore, based on molecular phylogeny, species names were corrected and four novel mycetoma causative agents were identified. By mapping mycetoma causative agents an association with Acacia trees was found. For early diagnosis, three different isothermal amplification techniques were developed, and novel antigens were discovered. To develop better treatment strategies for mycetoma patients, in vitro susceptibility tests for the coelomycete agents of black grain mycetoma were developed, and the first randomized clinical trial for eumycetoma started early 2017.
引用
收藏
页码:S153 / S164
页数:12
相关论文
共 50 条
  • [1] Closing the knowledge gap
    Marscher, WD
    [J]. CHEMICAL PROCESSING, 2002, 65 (10): : 39 - +
  • [2] The Mycetoma Knowledge Gap: Identification of Research Priorities
    van de Sande, Wendy W. J.
    Maghoub, El Sheikh
    Fahal, Ahmed H.
    Goodfellow, Michael
    Welsh, Oliverio
    Zijlstra, Ed
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (03):
  • [3] Closing the xylazine knowledge gap
    Hoffman, Robert S.
    [J]. CLINICAL TOXICOLOGY, 2023, 61 (12) : 1013 - 1016
  • [4] Closing the scientific knowledge gap: Comments
    Fulgoni, V
    [J]. JOURNAL OF NUTRITION, 2005, 135 (02): : 357 - 357
  • [5] DEMYSTIFYING DEFENSE - CLOSING THE KNOWLEDGE GAP
    TOBIAS, S
    [J]. SOCIAL POLICY, 1983, 13 (03) : 29 - 32
  • [6] Closing the knowledge gap on the composition of the asbestos bodies
    Bardelli, F.
    Giacobbe, C.
    Ballirano, P.
    Borelli, V.
    Di Benedetto, F.
    Montegrossi, G.
    Bellis, D.
    Pacella, A.
    [J]. ENVIRONMENTAL GEOCHEMISTRY AND HEALTH, 2023, 45 (07) : 5039 - 5051
  • [7] TAFI and wound healing: closing a knowledge gap
    Boffa, MB
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (10) : 2075 - 2077
  • [8] Transplantation for chagas' disease: closing the knowledge gap
    La Hoz, Ricardo M.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (05) : 397 - 403
  • [9] Women's health: Closing the knowledge gap
    Falkner, KL
    [J]. AMERICAN JOURNAL OF NURSING, 1996, 96 (05) : 17 - 17
  • [10] Osteoporotic fracture management: closing the gap of knowledge
    Goldhahn, J.
    Blauth, M.
    [J]. ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2007, 127 (01) : 1 - 2